Search

everythinglearnresearchcommunity

for

Search:↓

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Careful medical care is needed for those over 50 on hormone therapy during COVID-19.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Certain symptoms and patient profiles, like thoracic pain and general malaise, increase the risk of COVID-19 patients being readmitted to the emergency department.

Physical activity increased, but sedentary behavior also rose, especially in men.

Mesenchymal stromal cell therapies show promise for treating various diseases but need more research and standardization.

Hair transplantation is an effective hair loss treatment with two main techniques, requires careful planning, and can improve beard and eyebrows appearance.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

Pharmacist-led care significantly improved post-COVID symptoms.

The pandemic stress may have increased alopecia cases in Bangladesh.

COVID-19 can cause over 50 long-term symptoms, with fatigue and headache being the most common.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

COVID-19 vaccines can cause minor skin reactions, including those related to Bullous Pemphigoid, but these usually resolve on their own.

Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

The COVID-19 pandemic has increased hair loss and psychological distress in women.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

COVID-19 can cause long-term health issues in many body systems, and vaccination is important to prevent these effects.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

More symptoms during initial COVID infection increase the risk of long-term effects.

Long COVID sufferers face significant challenges that need more public awareness and support.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Ayurvedic Rasayan formulations like Chyawanprash may help manage post-COVID symptoms by boosting immunity.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.